A former scientist at Google's DeepMind who co-developed the AlphaFold2 protein prediction platform, Dr Simon Kohl, has launched his own venture applying artificial intelligence to drug discovery.

The structure of new proteins predicted by AlphaFold2 can be compared with ... Does the actual structure match the expected architecture and the intended function? This is the ultimate test ...

The company was founded by Dr Simon Kohl, previously a co-lead of DeepMind’s protein design team and a senior research scientist on DeepMind’s AlphaFold2, the project which earned a Nobel ...